Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis
Psoriasis is a complex chronic inflammatory cutaneous disorder. To date, robust molecular mechanisms of psoriasis have been reported. Among diverse aberrant immunopathogenetic mechanisms, the current model emphasizes the role of Th1 and the IL-23/Th17 axis, skin-resident immune cells and major signa...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/18/12/2684 |
id |
doaj-871e3df9c10947a39f29efc9f13422af |
---|---|
record_format |
Article |
spelling |
doaj-871e3df9c10947a39f29efc9f13422af2020-11-25T01:30:37ZengMDPI AGInternational Journal of Molecular Sciences1422-00672017-12-011812268410.3390/ijms18122684ijms18122684Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: PsoriasisYu Ri Woo0Dae Ho Cho1Hyun Jeong Park2Department of Dermatology, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 07345, KoreaDepartment of Life Science, Sookmyung Women’s University, Seoul 04310, KoreaDepartment of Dermatology, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 07345, KoreaPsoriasis is a complex chronic inflammatory cutaneous disorder. To date, robust molecular mechanisms of psoriasis have been reported. Among diverse aberrant immunopathogenetic mechanisms, the current model emphasizes the role of Th1 and the IL-23/Th17 axis, skin-resident immune cells and major signal transduction pathways involved in psoriasis. The multiple genetic risk loci for psoriasis have been rapidly revealed with the advent of a novel technology. Moreover, identifying epigenetic modifications could bridge the gap between genetic and environmental risk factors in psoriasis. This review will provide a better understanding of the pathogenesis of psoriasis by unraveling the complicated interplay among immunological abnormalities, genetic risk foci, epigenetic modification and environmental factors of psoriasis. With advances in molecular biology, diverse new targets are under investigation to manage psoriasis. The recent advances in treatment modalities for psoriasis based on targeted molecules are also discussed.https://www.mdpi.com/1422-0067/18/12/2684biologicsepigeneticsgeneticsinterleukin-23psoriasissignaling pathwaysmall moleculesT helper 17 cells |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yu Ri Woo Dae Ho Cho Hyun Jeong Park |
spellingShingle |
Yu Ri Woo Dae Ho Cho Hyun Jeong Park Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis International Journal of Molecular Sciences biologics epigenetics genetics interleukin-23 psoriasis signaling pathway small molecules T helper 17 cells |
author_facet |
Yu Ri Woo Dae Ho Cho Hyun Jeong Park |
author_sort |
Yu Ri Woo |
title |
Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis |
title_short |
Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis |
title_full |
Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis |
title_fullStr |
Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis |
title_full_unstemmed |
Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis |
title_sort |
molecular mechanisms and management of a cutaneous inflammatory disorder: psoriasis |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2017-12-01 |
description |
Psoriasis is a complex chronic inflammatory cutaneous disorder. To date, robust molecular mechanisms of psoriasis have been reported. Among diverse aberrant immunopathogenetic mechanisms, the current model emphasizes the role of Th1 and the IL-23/Th17 axis, skin-resident immune cells and major signal transduction pathways involved in psoriasis. The multiple genetic risk loci for psoriasis have been rapidly revealed with the advent of a novel technology. Moreover, identifying epigenetic modifications could bridge the gap between genetic and environmental risk factors in psoriasis. This review will provide a better understanding of the pathogenesis of psoriasis by unraveling the complicated interplay among immunological abnormalities, genetic risk foci, epigenetic modification and environmental factors of psoriasis. With advances in molecular biology, diverse new targets are under investigation to manage psoriasis. The recent advances in treatment modalities for psoriasis based on targeted molecules are also discussed. |
topic |
biologics epigenetics genetics interleukin-23 psoriasis signaling pathway small molecules T helper 17 cells |
url |
https://www.mdpi.com/1422-0067/18/12/2684 |
work_keys_str_mv |
AT yuriwoo molecularmechanismsandmanagementofacutaneousinflammatorydisorderpsoriasis AT daehocho molecularmechanismsandmanagementofacutaneousinflammatorydisorderpsoriasis AT hyunjeongpark molecularmechanismsandmanagementofacutaneousinflammatorydisorderpsoriasis |
_version_ |
1725091081427615744 |